Literature DB >> 9039618

Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis.

L C Maas1, G J Harris, A Satlin, C D English, R F Lewis, P F Renshaw.   

Abstract

Dynamic susceptibility contrast (DSC) MRI is an alternative to positron emission tomography (PET) and single photon emission computed tomography (SPECT) for the evaluation of cerebral hemodynamics in patients with Alzheimer's disease. DSC MRI allows the construction of high resolution images of cerebral blood volume (CBV) without the use of radionuclides or ionizing radiation. In this study, DSC MRI data were collected from 16 patients with probable Alzheimer's disease and 16 age-matched control subjects. Characteristic patterns of regional CBV variation were found using principal component analysis. Three such patterns were identified: a global variation pattern, an anterior-to-posterior CBV gradient, and a temporoparietal pattern. Group differences in the principal component scores associated with the global and temporoparietal patterns (P = .08 and P = .007, respectively) suggest that these deficits reflect characteristic CBV abnormalities in Alzheimer's disease. Using only these two scores, the Alzheimer's disease group was classified with a sensitivity of 81% and a specificity of 88%. Additionally, disease severity, as measured by the Mini-Mental State Examination (MMSE), was correlated significantly with the third principal component score (Pearson's r = .50, P = .05).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039618     DOI: 10.1002/jmri.1880070133

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.

Authors:  Stephan J Schreiber; Florian Doepp; Eike Spruth; Ute A Kopp; José M Valdueza
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

Review 2.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

Review 3.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

4.  Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Aleksandra Wabik; Elżbieta Trypka; Joanna Bladowska; Mikołaj Statkiewicz; Marek Sąsiadek; Anna Zimny
Journal:  J Transl Med       Date:  2022-06-07       Impact factor: 8.440

5.  Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Authors:  Thomas Mueggler; Christine Sturchler-Pierrat; Diana Baumann; Martin Rausch; Matthias Staufenbiel; Markus Rudin
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

6.  Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity.

Authors:  Jinsoo Uh; Kelly Lewis-Amezcua; Kristin Martin-Cook; Yamei Cheng; Myron Weiner; Ramon Diaz-Arrastia; Michael Devous; Dinggang Shen; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2009-02-05       Impact factor: 4.673

7.  Non-invasive quantification of absolute cerebral blood volume during functional activation applicable to the whole human brain.

Authors:  Pelin Aksit Ciris; Maolin Qiu; Robert Todd Constable
Journal:  Magn Reson Med       Date:  2014-02       Impact factor: 4.668

8.  The blood-brain barrier and microvascular water exchange in Alzheimer's disease.

Authors:  Valerie C Anderson; David P Lenar; Joseph F Quinn; William D Rooney
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-05-04

9.  Diagnosis of Alzheimer's Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy.

Authors:  Miguel A Chávez-Fumagalli; Pallavi Shrivastava; Jorge A Aguilar-Pineda; Rita Nieto-Montesinos; Gonzalo Davila Del-Carpio; Antero Peralta-Mestas; Claudia Caracela-Zeballos; Guillermo Valdez-Lazo; Victor Fernandez-Macedo; Alejandro Pino-Figueroa; Karin J Vera-Lopez; Christian L Lino Cardenas
Journal:  J Alzheimers Dis Rep       Date:  2021-01-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.